Similar Papers

Paper Title
Journal
Date
Author
Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naïve Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study
Yuankai Shi ...
Blood | VOL. 138
Yuankai Shi, et. al.Yuankai Shi ...
05 Nov 2021
Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Greg L Plosker ... David P Figgitt
Drugs | VOL. 63
Greg L Plosker, et. al.Greg L Plosker ... David P Figgitt
01 Jan 2003
Effect of the addition of rituximab to front line therapy with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) on the remission rate and time to treatment failure (TTF) compared to CHOP alone in mantle cell lymphoma (MCL): Results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)
W Hiddemann ... C Pott
Journal of Clinical Oncology | VOL. 22
W Hiddemann, et. al.W Hiddemann ... C Pott
15 Jul 2004
Granulocyte-Colony Stimulating Factor (G-CSF) May Improve Disease Outcome in Elderly Patients with Diffuse Large Cell Lymphoma (DLCL) Treated with CHOP Chemotherapy
Gerard B Donnelly ... Carol S Portlock
Leukemia & Lymphoma | VOL. 39
Gerard B Donnelly, et. al.Gerard B Donnelly ... Carol S Portlock
01 Jan 1999
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment
Simon Turcotte ... Stephanie L Goff
Journal for ImmunoTherapy of Cancer | VOL. 13
Simon Turcotte, et. al.Simon Turcotte ... Stephanie L Goff
20 Jan 2025
Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines
Anton Lahusen ... Yuan-Na Lin
Journal for ImmunoTherapy of Cancer | VOL. 13
Anton Lahusen, et. al.Anton Lahusen ... Yuan-Na Lin
16 Jan 2025
Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors
Blessie E Nelson ... Sarina A Piha-Paul
Journal for ImmunoTherapy of Cancer | VOL. 13
Blessie E Nelson, et. al.Blessie E Nelson ... Sarina A Piha-Paul
16 Jan 2025
Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors
Wenhao Hu ... Yi Zhang
Journal for ImmunoTherapy of Cancer | VOL. 13
Wenhao Hu, et. al.Wenhao Hu ... Yi Zhang
16 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.